Human Atrial Fibrillation: Insights From Computational Electrophysiological Models

Trends in Cardiovascular Medicine

Volumn 21, Issue 5, 2011, Pages 145-150

  Bers, Donald M ^a   Grandi, Eleonora ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIARRHYTHMIC AGENT; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION;

DISEASE COURSE; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MATHEMATICAL MODEL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; VAGUS NERVE STIMULATION;

ATRIAL FIBRILLATION; COMPUTER SIMULATION; ELECTROPHYSIOLOGY; HUMANS; SIGNAL TRANSDUCTION;

EID: 84862736456     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.04.004     Document Type: Review

References (65)

1. Aguilar-Shardonofsky M., Vigmond E.J., Nattel S., Comtois P. In silico optimization of atrial fibrillation-selective sodium channel blocker pharmacodynamics. Biophys J 2012, 102:951-960.
2. Ashihara T., Haraguchi R., Nakazawa K., et al. The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation: Implications for electrogram-based catheter ablation. Circ Res 2012, 110:275-284.
3. Aslanidi O.V., Colman M.A., Stott J., et al. 3D virtual human atria: A computational platform for studying clinical atrial fibrillation. Prog Biophys Mol Biol 2011, 107:156-168.
4. Bers D.M., Grandi E. Calcium/calmodulin-dependent kinase II regulation of cardiac ion channels. J Cardiovasc Pharmacol 2009, 54:180-187.
5. Caballero R., de la Fuente M.G., Gómez R., et al. In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both. J Am Coll Cardiol 2010, 55:2346-2354.
6. Carnes C.A., Janssen P.M., Ruehr M.L., et al. Atrial glutathione content, calcium current, and contractility. J Biol Chem 2007, 282:28063-28073.
7. Cherry E.M., Hastings H.M., Evans S.J. Dynamics of human atrial cell models: Restitution, memory, and intracellular calcium dynamics in single cells. Prog Biophys Mol Biol 2008, 98:24-37.
8. 2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 2004, 110:2651-2657.
9. + channel blockers: Insights from mathematical models and experimental correlates. Am J Physiol Heart Circ Physiol 2008, 295:H1489-H1504.
10. Courtemanche M., Ramirez R.J., Nattel S. Ionic mechanisms underlying human atrial action potential properties: Insights from a mathematical model. Am J Physiol Heart Circ Physiol 1998, 275:H301-H321.
11. Courtemanche M., Ramirez R.J., Nattel S. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: Insights from a mathematical model. Cardiovasc Res 1999, 42:477-489.
12. Decker K.F., Heijman J., Silva J.R., et al. Properties and ionic mechanisms of action potential adaptation, restitution, and accommodation in canine epicardium. Am J Physiol Heart Circ Physiol 2009, 296:H1017-H1026.
13. Dibb K.M., Clarke J.D., Horn M.A., et al. Characterization of an extensive transverse tubular network in sheep atrial myocytes and its depletion in heart failure. Circ Heart Fail 2009, 2:482-489.
14. K,ACh is constitutively active in patients with chronic atrial fibrillation. Circulation 2005, 112:3697-3706.
15. 2+ handling in human chronic atrial fibrillation. Circulation 2006, 114:670-680.
16. i overloaded cardiac myocytes: A simulation study. Biophys J 2000, 78:2392-2404.
17. Fearon I.M., Brown S.T. Acute and chronic hypoxic regulation of recombinant hNa(v)1.5 alpha subunits. Biochem Biophys Res Commun 2004, 324:1289-1295.
18. 2+ model: Sinus rhythm and chronic atrial fibrillation. Circ Res 2011, 109:1055-1066.
19. Grandi E., Pasqualini F.S., Bers D.M. A novel computational model of the human ventricular action potential and Ca transient. J Mol Cell Cardiol 2010, 48:112-121.
20. Grandi E., Workman A.J., Pandit S.V. Altered excitation-contraction coupling in human chronic atrial fibrillation. J Atr Fibrillation 2 (in press) 2012.
21. Harrild D., Henriquez C. A computer model of normal conduction in the human atria. Circ Res 2000, 87:E25-E36.
22. 2+-transient. J Mol Cell Cardiol 2011, 50:863-871.
23. Howe C.J., Lahair M.M., McCubrey J.A., Franklin R.A. Redox regulation of the calcium/calmodulin-dependent protein kinases. J Biol Chem 2004, 279:44573-44581.
24. Iyer V., Mazhari R., Winslow R.L. A computational model of the human left-ventricular epicardial myocyte. Biophys J 2004, 87:1507-1525.
25. Jacquemet V., van Oosterom A., Vesin J.M., Kappenberger L. Analysis of electrocardiograms during atrial fibrillation: A biophysical model approach. IEEE Eng Med Biol Mag 2006, 25:79-88.
26. Jalife J. Déjà vu in the theories of atrial fibrillation dynamics. Cardiovasc Res 2011, 89:766-775.
27. Koivumaki J.T., Korhonen T., Tavi P. Impact of sarcoplasmic reticulum calcium release on calcium dynamics and action potential morphology in human atrial myocytes: A computational study. PLoS Comput Biol 2011, 7:e1001067.
28. + channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts. Circulation 1994, 90:2213-2224.
29. Krogh-Madsen T., Abbott G.W., Christini D.J. Effects of electrical and structural remodeling on atrial fibrillation maintenance: A simulation study. PLoS Comput Biol 2012, 8:e1002390.
30. Kuo S.R., Trayanova N.A. Action potential morphology heterogeneity in the atrium and its effect on atrial reentry: A two-dimensional and quasi-three-dimensional study. Philos Transact A Math Phys Eng Sci 2006, 364:1349-1366.
31. 2+ release in right atrial myocytes from experimental persistent atrial fibrillation. Circ Res 2009, 105:876-885.
32. + current in human atrial myocytes. Circ Res 1996, 78:903-915.
33. + channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation. J Physiol 2009, 587:1087-1100.
34. MacCannell K.A., Bazzazi H., Chilton L., et al. A mathematical model of electrotonic interactions between ventricular myocytes and fibroblasts. Biophys J 2007, 92:4121-4132.
35. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res 2007, 73:631-640.
36. Makary S., Voigt N., Maguy A., et al. Differential protein kinase C isoform regulation and increased constitutive activity of acetylcholine-regulated potassium channels in atrial remodeling. Circ Res 2011, 109:1031-1043.
37. + current changes account for the rate dependence of the action potential in the human atrial myocyte. Am J Physiol Heart Circ Physiol 2009, 297:H1398-H1410.
38. Maleckar M.M., Greenstein J.L., Trayanova N.A., Giles W.R. Mathematical simulations of ligand-gated and cell-type specific effects on the action potential of human atrium. Prog Biophys Mol Biol 2008, 98:161-170.
39. Medi C., Sparks P.B., Morton J.B., et al. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: Results from long-term follow-up. J Cardiovasc Electrophysiol 2011, 22:137-141.
40. Mihm M.J., Yu F., Carnes C.A., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001, 104:174-180.
41. Nagy N., Szuts V., Horváth Z., et al. Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization?. J Mol Cell Cardiol 2009, 47:656-663.
42. 2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ Res 2010, 106:1134-1144.
43. Núñez L., Vaquero M., Gómez R., et al. Nitric oxide blocks hKv15 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc Res 2006, 72:80-89.
44. + currents in repolarization. Circ Res 1998, 82:63-81.
45. Pandit S.V., Berenfeld O., Anumonwo J.M., et al. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J 2005, 88:3806-3821.
46. Qi X.Y., Yeh Y.H., Xiao L., et al. Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res 2008, 103:845-854.
47. Richards M.A., Clarke J.D., Saravanan P., et al. Transverse tubules are a common feature in large mammalian atrial myocytes including human. Am J Physiol Heart Circ Physiol 2011, 301:H1996-H2005.
48. + pump is an important modulator of refractoriness and rotor dynamics in human atrial tissue. Am J Physiol Heart Circ Physiol 2012, 302:H1146-H1159.
49. Sanders P., Berenfeld O., Hocini M., et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation 2005, 112:789-797.
50. Seemann G., Hoper C., Sachse F.B., et al. Heterogeneous three-dimensional anatomical and electrophysiological model of human atria. Philos Transact A Math Phys Eng Sci 2006, 364:1465-1481.
51. 2+ handling. Biophys J 2010, 99:2038-2047.
52. + currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol 2010, 55:2330-2342.
53. 2+/calmodulin-dependent protein kinases II in human atrial myocytes. Circ Res 1999, 85:810-819.
54. Kr blockers on cardiac action potential duration in a human atrial model. Am J Physiol Heart Circ Physiol 2007, 293:H660-H669.
55. Van Wagoner D.R. Oxidative stress and inflammation in atrial fibrillation: Role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 2008, 52:306-313.
56. 2+ currents and human atrial fibrillation. Circ Res 1999, 85:428-436.
57. + current densities and Kv15 expression are reduced in chronic human atrial fibrillation. Circ Res 1997, 80:772-781.
58. 2+ signaling in patients with chronic atrial fibrillation. Circulation 2009, 120:S667-S668.
59. Voigt N., Trausch A., Knaut M., et al. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm J Electrophysiol 2010, 3:472-480.
60. Wakili R., Voigt N., Kääb S., et al. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 2011, 121:2955-2968.
61. Wang Z., Fermini B., Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res 1993, 73:276-285.
62. Workman A.J. Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 2010, 381:235-249.
63. Workman A.J., Kane K.A., Rankin A.C. The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res 2001, 52:226-235.
64. K1 in action potential shortening associated with atrial fibrillation in humans. Cardiovasc Res 2005, 66:493-502.
65. Zima A.V., Blatter L.A. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006, 71:310-321.